18 eredmény a kulcsszóra: 'epidermal growth factor'
At indicated times thereafter duplicate dishes from cultures growing in the presence (o) or absence (·) of hEGF were removed and the cell numbers determined. At the times
N/A
(2008) Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. (2007) Epidermal growth factor receptor copy number
N/A
The author has examined the effect of the signal transduction molecules as: IGF ((Insulin-like Growth Factor), EGF (Epidermal Growth Factor), VEGF (Vascular Endothelia Growth
N/A
(1993) Effects of epidermal growth factor, insulin-like growth factor-I, and dialysed porcine follicular fluid on porcine oocyte maturation in vitro. (1988) Coculture
N/A
In Education and Technology – key issues and debates Neil Selwyn summarises current and highly-disputed topics in the field of educational technology.. It explores problem
N/A
DFS = (disease-free survival) betegségmentes túlélés; EGFR = (epidermal growth factor receptor) epidermális növekedési fak- tor receptor; EMA = epithelialis membránantigén; FIGO =
N/A
Binding interactions between human serum albumin (HSA) and four approved epidermal growth factor receptor (EGFR) inhibitors gefitinib (GEF), erlotinib (ERL), afatinib (AFA),
N/A
Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. ORAL
N/A
S1 X-ray diffractometry patterns of diclofenac anion-intercalated LDH samples intercalated in ethanol-water mixtures of varying compositions (1:1 Fe(III):diclofenac
N/A
Aim To evaluate (I) trastuzumab-containing primary systemic therapy (PST) in human epidermal growth factor receptor 2 (Her2) overexpressing breast carcinomas.; (II)
N/A
Logit regression on the correlation between the recombinant human epidermal growth factor (rhEGF) application frequency (horizontal axis—measured in weeks) and complete healing
N/A
When epidermal growth factor receptor (EGFR) mutation was detected in patients with pulmonary adenocarcinomas and subsequent specific treatment with tyrosine kinase inhibitors
N/A
(2006) Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clinical cancer research :
N/A
(2013) Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.. Tanizaki
N/A
(2012) Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer
N/A
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth
N/A
(E) HaCaT cells were stimulated with thapsigargin in the presence of 600 or 1200 U/ml catalase and then processed for Trx1 western blot as described above. This experiment
N/A